Combined Ultrasmall Superparamagnetic Particles of Iron Oxide-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Reliably Detect Pelvic Lymph Node Metastases in Normal-Sized Nodes of Bladder and Prostate Cancer Patients

European Urology

Volumn 55, Issue 4, 2009, Pages 761-769

  Thoeny, Harriet C ^a   Triantafyllou, Maria ^a   Birkhaeuser, Frederic D ^a   Froehlich, Johannes M ^b   Tshering, Dechen W ^a   Binser, Tobias ^c   Fleischmann, Achim ^c   Vermathen, Peter ^c   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Department of Urology ^*  (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bladder cancer; Diffusion weighted MRI; Extended pelvic lymphadenectomy; Lymph node metastasis; Prostate cancer; USPIO

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; CONTRAST MEDIA; DEXTRANS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FERROSOFERRIC OXIDE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; URINARY BLADDER NEOPLASMS;

EID: 60249092434     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.12.034     Document Type: Article

References (22)

1. Studer U.E., Scherz S., Scheidegger J., et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144 (1990) 243-245
2. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849-854
3. Fleischmann A., Thalmann G.N., Markwalder R., and Studer U.E. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 23 (2005) 2358-2365
4. Schumacher M.C., Burkhard F.C., Thalmann G.N., Fleischmann A., and Studer U.E. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol 54 (2008) 344-352
5. Mills R.D., Fleischmann A., and Studer U.E. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results. Surg Oncol Clin N Am 16 (2007) 233-245
6. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
7. Deserno W.M., Harisinghani M.G., Taupitz M., et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233 (2004) 449-456
8. In: Siegel S., and Castellan J. (Eds). Nonparametric Statistics for the Behavioral Sciences (1988), McGraw-Hill, New York, NY
9. Randolph JJ. Online kappa calculator. http://justus.randolph.name/kappa. Accessed December 2, 2008.
10. Mills R.D., Turner W.H., Fleischmann A., Markwalder R., Thalmann G.N., and Studer U.E. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166 (2001) 19-23
11. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19 (2001) 666-675
12. Jeschke S., Beri A., Grüll M., et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol 53 (2008) 126-133
13. Retz M., Lehmann J., Szysnik C., et al. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR. Eur Urol 45 (2004) 314-319
14. Theodorescu D., and Frierson Jr. H.F. When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancer. Urol Oncol 22 (2004) 256-259
15. Weissleder R., Elizondo G., Wittenberg J., Lee A.S., Josephson L., and Brady T.J. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175 (1990) 494-498
16. Harisinghani M.G., Dixon W.T., Saksena M.A., et al. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 24 (2004) 867-878
17. Bellin M.F., Lebleu L., and Meric J.B. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 28 (2003) 155-163
18. Heesakkers R.A., Hövels A.M., Jager G.J., et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9 (2008) 850-856
19. Rockall A.G., Sohaib S.A., Harisinghani M.G., et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23 (2005) 2813-2821
20. Hamm BK, Caseiro-Alves F, Bellin M, et al. USPIO-enhanced intravenous MR lymphography for staging pelvic cancers: results of a European multicenter phase III trial including 271 patients. Paper presented at: the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America; November 25-30, 2007; Chicago, IL.
21. King A.D., Ahuja A.T., Yeung D.K., et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR-imaging. Radiology 245 (2007) 806-813
22. Kim J.K., Kim K.A., Park B.W., Kim N., and Cho K.S. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 28 (2008) 714-719